The Early Experience of Synchrony in Ultra-Hypofractionation for Prostate Cancer: A Case Series
Toapichattrakul P, Muangwong P, Kongsa A, et al. | Cureus Competition | 2025
3089: Early Report on Acute and Late Toxicity of Helical Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost for Cancer Prostate
Cheikh Tayeb et al. | ESTRO | 2025
3898: One-day Urethral-sparing, HDR-like, Prostate Cancer Robotic SBRT: Preliminary Results of the PRO-FAST Trial
Andrei Fodor et al. | ESTRO | 2025
3734: Analysis and Comparison of CyberKnife MLC Collimator Versus IRIS Collimator in Prostate SBRT
Gaetano Gagliardo et al. | ESTRO | 2025
3492: CyberKnife UH-SBRT for Localized Prostate Cancer and DIL: Preliminary Report of Acute and Late Toxicity of the PRO-SPEED Trial (NCT06331013)
Giovanni Carlo Mazzola et al. | ESTRO | 2025
2803: Comparison of Radiotherapy with CyberKnife or Low Dose Rate Brachytherapy of Low-intermediate Risk Prostate Cancer Patients After Six-year Follow-up
Péter Ágoston et al. | ESTRO | 2025
2344: Long-term Outcomes and Treatment Efficacy in High-risk Prostate Cancer Patients Treated with Stereotactic Extreme Hypofractionated Radiotherapy
Vivien Molnár et al. | ESTRO | 2025
1653: Early Results from a Trial on Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736)
Niccolo’ Bertini et al. | ESTRO | 2025
1021: RE-START: A National Registry Including Patients Undergoing Reirradiation After Previous RT for Prostate Cancer. A Study on Behalf of AIRO
Giulio Francolini et al. | ESTRO | 2025
Two Years’ Experience with Stereotactic Body Radiotherapy for Localized Prostate Cancer Using the CyberKnife System
Shaima Shoeir et al. | RSS | 2025
Urethra and Bladder Dosimetry in Patients Treated with Prostate SBRT with and without Intra-Prostatic Boost (IPB)
Nisha Bhargava et al. | ASTRO 2024
Early PSA Kinetics in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Nima Aghdam et al. | ASTRO 2024
Early Results from a Prospective Trial Testing Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736)
Giulio Francolini et al. | ASTRO 2024
Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Nisha Bhargava et al. | ASTRO 2024
Moderately Hypofractionated Helical TomoTherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
Cozzi S, Ruggieri MP, Alì E, Ghersi SF, Vigo F, Augugliaro M, Giaccherini L, Iori F, Najafi M, Bardoscia L, Botti A, Trojani V, Ciammella P, Iotti C | In Vivo | 2023
Salvage Stereotactic Reirradiation for Intraprostatic Cancer Recurrence: A Large Retrospective Study
Allali S, Loap P, Bibault JE, Krepps S, Deforge A, Moreau D, Durdux C, Giraud P | Prostate | 2023
Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultra-hypofractionated Stereotactic Body Radiotherapy
Piotr Milecki, Anna Adamska, Anna Rucinska, Grzegorz Pałucki, Agnieszka Szumiło, Agnieszka Skrobała, Agata Jodda, Michał Michalak | J Pers Med | 2023
Stereotactic Body Radiation Therapy for Prostate Cancer: A Study Comparing 3-year Genitourinary Toxicity Between CyberKnife and Volumetric-Modulated Arc Therapy by Propensity Score Analysis
Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda, Kojiro Suzuki | Radiat Oncol | 2023
Robotic Stereotactic Body Radiotherapy for Localized Prostate Cancer: Final Analysis of the German Hypostat Trial
David Krug, Detlef Imhoff, Alfred Haidenberger, Nicole Heßler, Jane Schäfer, Stefan Huttenlocher, Georgios Chatzikonstantinou, Christoph Fürweger, Ulla Ramm, Inke R König, Felix Chun, Michael Staehler, Claus Rödel, Alexander Muacevic, Reinhard Vonthein, Jürgen Dunst, Oliver Blanck | Strahlenther Onkol | 2023
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]
